Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for Research and Development); Rahway, New Jersey, 78845 [2024-22102]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 187 / Thursday, September 26, 2024 / Notices
information provided. Only include
information you would like to be made
public.
Instructions: Response to this RFC is
voluntary. Responses should include
the name of the person(s) or
organization(s) filing the response.
Responses containing references,
studies, research, and other empirical
data that are not widely published
should include copies of or electronic
links to the referenced materials. Please
do not submit copyrighted material.
OPOG will not consider responses
containing profanity, vulgarity, threats,
or other inappropriate language or
content. Any information obtained from
this RFC is intended to be used by the
Government on a non-attribution basis.
The Department of Commerce will not
respond to individual submissions.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information
should be directed to open@doc.gov
with ‘‘Open Government Plan RFC’’ in
the subject line, or by mail to Office of
Privacy and Open Government, U.S.
Department of Commerce, Attn: Jennifer
Goode, Ph.D., Deputy Director for Open
Government and Departmental Privacy
Act Officer, 1401 Constitution Ave. NW,
Mail Stop 61013, Washington, DC
20230, (202) 482–1190.
SUPPLEMENTARY INFORMATION: In
accordance with OMB Memorandum
M–09–12, President’s Memorandum on
Transparency and Open Government—
Interagency Collaboration, OMB
Memorandum M–10–06, Open
Government Directive, and OMB
Memorandum M–16–16, 2016 Agency
Open Government Plans, the
Department continues to develop,
publish, and update its Open
Government Plan every two years. The
Plan describes how the Department
continuously strives to improve
transparency and integrate public
participation and collaboration into its
activities. In September 2022, the
Department published the seventh
version of its Open Government Plan,
building on the Department’s long
history of innovative approaches to data
dissemination and highlighting the
adoption of new tools and technology to
facilitate the principles of open
government.
Now, as the Department develops the
eighth version of its Open Government
Plan, we welcome public input on how
to improve upon the approach we took
for the presentation of the seventh
version of the Open Government Plan,
including how to improve the
organization, scope, form and format of
the plan; enhance readability; and reach
a broader audience. We also welcome
VerDate Sep<11>2014
17:11 Sep 25, 2024
Jkt 262001
public input on how best to convey how
the Department will incorporate the
following themes from the fifth U.S.
Open Government National Action Plan,
issued on December 28, 2022:
• improving access to government
data, research, and information;
• increasing civic space within which
to engage with the public;
• transforming government service
delivery;
• countering corruption and ensuring
government integrity and accountability
to the public; and
• ensuring equal justice under the
law.Please Note: The focus of this
request for information is the
presentation of the Department’s Open
Government Plan document. Comments
or suggestions for improvements to the
Department’s programs or activities in
furtherance of open government will not
be considered in connection with this
request for information.
To learn more about the Department’s
commitment to open government and to
access the seventh or previous versions
of the Department’s Open Government
Plan, visit www.commerce.gov/open. To
learn more about the fifth U.S. Open
Government National Action Plan, visit:
https://open.usa.gov/national-actionplan/5/.
Charles R. Cutshall,
Department of Commerce, Director of Open
Government, Office of Privacy and Open
Government.
[FR Doc. 2024–21731 Filed 9–25–24; 8:45 am]
DEPARTMENT OF COMMERCE
[FR Doc. 2024–22102 Filed 9–25–24; 8:45 am]
BILLING CODE 3510–DS–P
Foreign-Trade Zones Board
[B–50–2024]
DEPARTMENT OF COMMERCE
Foreign-Trade Zone (FTZ) 49,
Notification of Proposed Production
Activity; Merck, Sharp & Dohme LLC;
(Pharmaceutical Products for
Research and Development); Rahway,
New Jersey
Merck, Sharp & Dohme LLC
submitted a notification of proposed
production activity to the FTZ Board
(the Board) for its facility in Rahway,
New Jersey, within Subzone 49Y. The
notification conforming to the
requirements of the Board’s regulations
(15 CFR 400.22) was received on
September 18, 2024.
Pursuant to 15 CFR 400.14(b), FTZ
production activity would be limited to
the specific foreign-status material(s)/
component(s) and specific finished
product(s) described in the submitted
notification (summarized below) and
Frm 00005
subsequently authorized by the Board.
The benefits that may stem from
conducting production activity under
FTZ procedures are explained in the
background section of the Board’s
website—accessible via www.trade.gov/
ftz. The proposed finished product and
material/component would be added to
the production authority that the Board
previously approved for the operation,
as reflected on the Board’s website.
The proposed finished product for
research and development is MK–6878
HIV drug product (duty-free).
The proposed foreign-status material/
component is MK–6878 HIV active
pharmaceutical ingredient (duty rate,
6.5%). The request indicates that this
material/component is subject to duties
under section 301 of the Trade Act of
1974 (section 301), depending on the
country of origin. The applicable section
301 decisions require subject
merchandise to be admitted to FTZs in
privileged foreign status (19 CFR
146.41).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is
November 5, 2024.
A copy of the notification will be
available for public inspection in the
‘‘Online FTZ Information System’’
section of the Board’s website.
For further information, contact Diane
Finver at Diane.Finver@trade.gov.
Dated: September 23, 2024.
Elizabeth Whiteman,
Executive Secretary.
BILLING CODE 3510–17–P
PO 00000
78845
Fmt 4703
Sfmt 4703
Foreign-Trade Zones Board
[B–29–2024]
Foreign-Trade Zone (FTZ) 32;
Authorization of Production Activity;
J.J.C. International Distributors LLC
dba Clar Company; (Galvanized Steel
Products); Miami, Florida
On May 23, 2024, J.J.C. International
Distributors LLC dba Clar Company
submitted a notification of proposed
production activity to the FTZ Board for
its facility within FTZ 32, in Miami,
Florida.
The notification was processed in
accordance with the regulations of the
FTZ Board (15 CFR part 400), including
notice in the Federal Register inviting
public comment (89 FR 47129, May 31,
2024). On September 20, 2024, the
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 89, Number 187 (Thursday, September 26, 2024)]
[Notices]
[Page 78845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22102]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-50-2024]
Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production
Activity; Merck, Sharp & Dohme LLC; (Pharmaceutical Products for
Research and Development); Rahway, New Jersey
Merck, Sharp & Dohme LLC submitted a notification of proposed
production activity to the FTZ Board (the Board) for its facility in
Rahway, New Jersey, within Subzone 49Y. The notification conforming to
the requirements of the Board's regulations (15 CFR 400.22) was
received on September 18, 2024.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status material(s)/component(s) and
specific finished product(s) described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via www.trade.gov/ftz. The proposed finished
product and material/component would be added to the production
authority that the Board previously approved for the operation, as
reflected on the Board's website.
The proposed finished product for research and development is MK-
6878 HIV drug product (duty-free).
The proposed foreign-status material/component is MK-6878 HIV
active pharmaceutical ingredient (duty rate, 6.5%). The request
indicates that this material/component is subject to duties under
section 301 of the Trade Act of 1974 (section 301), depending on the
country of origin. The applicable section 301 decisions require subject
merchandise to be admitted to FTZs in privileged foreign status (19 CFR
146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
[email protected]. The closing period for their receipt is November 5,
2024.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Diane Finver at
[email protected].
Dated: September 23, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-22102 Filed 9-25-24; 8:45 am]
BILLING CODE 3510-DS-P
